FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1363981000168109: insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 5 x 3 mL pen devices (medicinal product pack)

Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4152011000168118 insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 5 x 3 mL pen devices (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4152021000168113 insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices en Synonym Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices Is a insulin glargine 100 units/mL injection, 5 x 3 mL pen devices true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices has MPUU insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Soliqua 100/50 injection, 5 x 3 mL pen devices Is a True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices Inferred relationship Some

Reference Sets

List of Medicines for Brand Consideration reference set

Medicinal product pack reference set

Back to Start